CORRECTION article

Front. Immunol., 14 June 2024

Sec. Cancer Immunity and Immunotherapy

Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1397764

Corrigendum: Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer

  • 1. Department of Thoracic Oncology, Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China

  • 2. National Clinical Research Center for Cancer, Tianjin, China

  • 3. Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

  • 4. Tianjin’s Clinical Research Center for Cancer, Tianjin, China

  • 5. Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China

  • 6. Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

  • 7. Wenzhou Central Hospital, Wenzhou, Zhejiang, China

  • 8. Department of head and neck surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China

  • 9. Department of Pathology, Shanxi Bethune Hospital, Taiyuan, Shanxi, China

  • 10. General Surgery Department, Shanxi Bethune Hospital, Taiyuan, Shanxi, China

  • 11. Haihe Laboratory of Cell Ecosystem, Tianjin, China

  • 12. Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

In the published article, there was an error in affiliation(s) 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13. Instead of “2Tianjin Medical University Cancer Institute and Hospital, Tianjin China, 3National Clinical Research Center for Cancer, Tianjin, China, 4Key Laboratory of Cancer Prevention and Therapy, Tianjin China, 5Tianjin’s Clinical Research Center for Cancer, Tianjin China, 6Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China, 7Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China, 8Wenzhou Central Hospital, Wenzhou, Zhejiang, China, 9Department of Head and Neck Surgery, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China, 10Department of Pathology, Shanxi Bethune Hospital, Taiyuan, Shanxi, China, 11General Surgery Department, Shanxi Bethune Hospital, Taiyuan, Shanxi, China, 12Haihe Laboratory of Cell Ecosystem, Tianjin, China, 13Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.”, it should be:” 2National Clinical Research Center for Cancer, Tianjin, China, 3Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, 4Tianjin’s Clinical Research Center for Cancer, Tianjin, China, 5Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China, 6Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China, 7Wenzhou Central Hospital, Wenzhou, Zhejiang, China, 8Department of head and neck surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China, 9Department of Pathology, Shanxi Bethune Hospital, Taiyuan, Shanxi, China, 10General Surgery Department, Shanxi Bethune Hospital, Taiyuan, Shanxi, China, 11Haihe Laboratory of Cell Ecosystem, Tianjin, China, 12Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

In the published article, there was an error regarding the affiliation(s) for Siyuan Zhang, Qiuru Zhou, Fei Han, Gang Du, Lin Wang, Xuena Yang, Xiying Zhang, Wenwen Yu, Feng Wei, Xishan Hao, Xiubao Ren and Hua Zhao.

Instead of Siyuan Zhang2,3,4,5,6,7†, Qiuru Zhou2,3,4,5,6,7,8, Fei Han9, Gang Du10, Lin Wang11, Xuena Yang7, Xiying Zhang7, Wenwen Yu7, Feng Wei7,12, Xishan Hao12, Xiubao Ren7,12,13* and Hua Zhao7,12*, it should be: Siyuan Zhang2,3,4,5,6†, Qiuru Zhou2,3,4,5,6,7, Fei Han8, Gang Du9, Lin Wang10, Xuena Yang2,3,4,5,6, Xiying Zhang2,3,4,5,6, Wenwen Yu2,3,4,5,6, Feng Wei2,3,4,5,6,11, Xishan Hao2,3,4,5,11, Xiubao Ren2,3,4,5,6,11,12* and Hua Zhao2,3,4,5,6,11*

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

TLS, CRC, dMMR, PMMR, anti-PD1 immunotherapy

Citation

Feng H, Zhang S, Zhou Q, Han F, Du G, Wang L, Yang X, Zhang X, Yu W, Wei F, Hao X, Ren X and Zhao H (2024) Corrigendum: Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer. Front. Immunol. 15:1397764. doi: 10.3389/fimmu.2024.1397764

Received

08 March 2024

Accepted

31 May 2024

Published

14 June 2024

Approved by

Frontiers in Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Xiubao Ren, ; Hua Zhao,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics